Fever - How to Take the Temperature

Recognizing Exceptional Care: Children's Colorado Shines in 5280's Top Docs Issue

The remarkable expertise and compassion of our Children's Colorado providers is inspiring. This dedication has once again merited recognition in 5280 Magazine's annual Top Doctors issue, an incredible 30th appearance.

Hereditary Cancer

Learn about the signs, symptoms, diagnosis and treatment of hereditary cancer in children. See how our specialists treat and diagnose hereditary cancer.

Neuropsychology

Learn more about the Neuropsychology Program at Children's Hospital Colorado, a division of the Neuroscience Institute.

Hematology and Oncology Resources for Healthcare Professionals

Get the latest in oncology and hematology professional healthcare resources to better your practice and learn about innovations in our Center for Cancer and Blood Disorders.

Demystifying a Novel Disease

Through whole-genome sequencing, immunologists identified a novel genetic mutation and unlocked information critical to treating a patient’s rare disease –– Pneumocystis jirovecii pneumonia.

Pediatric Oncologist at Children’s Hospital Colorado Leads Effort to Battle Childhood Cancer Around the World

For children living in high-income countries with access to excellent health care, the likelihood of surviving exceeds 80%. Unfortunately, the survival rate is only 15–45% for most children battling cancer who live in low-and middle-income countries. To address this, Sandra Luna-Fineman, MD, a pediatric oncologist at Children's Hospital Colorado, partnered with others to create the CureAll framework.

In Search of a Cure for Treatment-Induced Brain Tumors

After initial cancer treatments, a secondary, incurable tumor may form, known as a treatment-induced high-grade glioma. Thankfully, researchers are searching for a cure for these high-grade gliomas in children.

Addressing Bleeding Disorders in Young Women – The Spots and Dots Clinic

Our Spots and Dots clinic diagnoses and treats gynecological and hematologic issues in young women. Learn more about the services our clinic offers.

The Pediatric Blood and Marrow Transplant and Cellular Therapy Program

Our Pediatric Blood and Marrow Transplant and Cellular Therapy Program uses leading technologies and techniques to ensure the best care possible. Learn about our pediatric program.

The Effect of Pediatric Cancer on Identity in Young Adult Survivors: Results from Project REACH

Contrary to their hypothesis, researchers found that identifying as a survivor for young adults who had pediatric cancer is linked to higher anxiety and worse overall mental health.

Donating Blood at Children's Hospital Colorado

Many sick and injured infants, children and teens depend on blood donations for their survival. Give blood now to support lifesaving procedures.

Genetic Counseling for Patients with Blood Disorders

We offer genetic counseling to families with hereditary blood disorders. Identifying a hereditary blood disorder can help us deliver the best treatment.

Experimental Therapeutics Program for Cancer Treatment in Kids

Our Experimental Therapeutics Program offers innovative clinical trials for kids with recurrent forms of cancer. Learn more about our experimental cancer treatments.

The Wellness Program for Patients and Families in the Center for Cancer and Blood Disorders

The Cancer Wellness Program at Children’s Hospital Colorado helps families understand the impact of a cancer diagnosis and navigate their new normal.

Beckwith-Wiedemann Syndrome

Learn about the symptoms, diagnosis and treatment of Beckwith-Wiedemann syndrome in children.

Resources for Families of Patients with Cancer

Resources for families of cancer patients at Children’s Hospital Colorado including housing options, websites and support programs.

The HOPE Cancer and Bone Marrow Transplantation Survivorship Program

The HOPE Survivorship Program is one of the nation’s first programs focused on cancer survivorship. Here, we help pediatric cancer survivors manage their condition and live the fullest life possible.

A Novel PLK1 Inhibitor Onvansertib Effectively Sensitizes MYC-Driven Medulloblastoma to Radiotherapy

Researchers found that the new oral PLK1 Inhibitor onvansertib shows therapeutic promise for treating medulloblastoma when combined with radiation treatment.